• Overview
  • Details
  • More
Share Products Categories Channel Cart

1/6
Pharmaceutical Rapamycin Sirolimus Rapamycin图1Pharmaceutical Rapamycin Sirolimus Rapamycin图2Pharmaceutical Rapamycin Sirolimus Rapamycin图3Pharmaceutical Rapamycin Sirolimus Rapamycin图4Pharmaceutical Rapamycin Sirolimus Rapamycin图5Pharmaceutical Rapamycin Sirolimus Rapamycin图6

Pharmaceutical Rapamycin Sirolimus Rapamycin

Price $10.00
Min Order 1 g  
Shipping from Shaanxi, China
Quantity
-+
Product details
QS-Rapamycin
53123-88-9
C51h79no13
610-965-5
Negotiable
Normal
>12 Months
Rapamycin
Rapamycin
>99%
Rapamycin
Rapamycin Powder
White Powder
White
Pharmaceutical Grade
>99%
Pharmaceutica
COA
HPLC
C51h79no13
914.17186
185c
1.182
973.017c
2.4
QS-Rapamycin
Negotiable
>99%
Xi`an
Product Description
Pharmaceutical Rapamycin Sirolimus Rapamycin
Product Description
Product Details
NameRapamycin Powder
Product NameRapamycin
AppearanceWhite Powder
Assay>99%
ApplicationPharmaceutica
Melting Point185C
MFC51H79NO13
MV914.17186
Rapamycin a triene macrolide antibiotic, exhibits antifungal, anti-inflammatory, antitumor, and immunosuppressive properties. It inhibits T-cell activation and proliferation, suppresses p70 S6 kinase activation, and strongly binds to FK-506 binding proteins. Additionally, rapamycin targets the mammalian target of rapamycin, a protein involved in signaling pathways that promote tumor growth. By binding to the receptor protein FKBP12, the rapamycin FKBP12 complex interacts with mTOR, preventing its engagement with downstream target proteins and thereby inhibiting tumor progression.
Application&Function
Rapamycin, a triene macrolide antibiotic, possesses antifungal, anti-inflammatory, antitumor, and immunosuppressive effects. It effectively blocks T-cell activation and proliferation, inhibits the activation of p70 S6 kinase, and forms strong interactions with FK506 binding proteins. Additionally, rapamycin targets and suppresses the activity of mTOR (mammalian target of rapamycin), a protein that plays a key role in signaling pathways driving tumor growth. By binding to the receptor protein FKBP12, the resulting rapamycin/FKBP12 complex attaches to mTOR, disrupting its ability to interact with downstream target proteins and thereby inhibiting tumor-promoting signaling.
Specification

Buyer review
Loading review details...
Contact

Xi'an Qiushi Co., Ltd.

Audited Supplier1 Year
ProfileCertified by SGS/BV

Message Type

* Content

* Name

* Phone

* Email

* Captcha

captcha

Recommended for you